Long-term adjuvant tamoxifen therapy for breast cancer: The prelude to prevention

This publication has 74 references indexed in Scilit:

• The Risk of Breast Cancer after Estrogen and Estrogen–Progestin Replacement
  New England Journal of Medicine, 1989
• Contrasting ability of antiestrogens to inhibit MCF-7 growth stimulated by estradiol or epidermal growth factor
  European Journal of Cancer and Clinical Oncology, 1989
• Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer
  British Journal of Cancer, 1988
• Adjuvant tamoxifen in primary breast cancer: Influence on plasma lipids and antithrombin III levels
  Breast Cancer Research and Treatment, 1988
• A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer.
  Journal of Clinical Oncology, 1986
• Adjuvant Tamoxifen Treatment of Elderly Women with Stage II Breast Cancer
  Annals of Internal Medicine, 1985
• A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bd
  British Journal of Cancer, 1984
• Estrogen-Like Action of Tamoxifen on Vaginal Epithelium in Breast Cancer Patients
  Oncology, 1981
• A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474
  British Journal of Cancer, 1971
• Mammary Tumors in Mice in Relation to Nursing
  The American Journal of Cancer, 1937